Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2024

Open Access 23-12-2023 | Electrocardiography | Original article

Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease

Authors: Ken Hirabayashi, Hideki Fujii, Keiji Kono, Satoshi Yamatani, Mao Shimizu, Kentaro Watanabe, Kazuo Sakamoto, Shunsuke Goto, Shinichi Nishi

Published in: Clinical and Experimental Nephrology | Issue 4/2024

Login to get access

Abstract

Background

In patients with chronic kidney disease (CKD), the incidence of cardiovascular disease (CVD) increases with disease progression. CVD screening tests in those with CKD were researched to determine whether abnormalities observed in electrocardiography (ECG) and ultrasonic echocardiography (UCG) were risk factors associated with the development of CVD.

Methods

This study included 604 patients with CKD G4 and G5, for whom both ECG and UCG were performed. They were divided into four groups: those without ECG- and UCG-indicated abnormalities (group A, n = 333), with only ECG abnormalities (group B, n = 106), with only UCG abnormalities (group C, n = 75), and with both ECG and UCG abnormalities (group D, n = 90). Multivariate analysis using Cox regression analysis of the occurrence of CVD was performed during a follow-up period.

Results

During the observation period, 124 patients had clinical events. Among them, 45 patients (13.5%) were in Group A, 25 patients (23.6%) in Group B, 19 patients (25.3%) in Group C, and 35 patients (38.9%) in Group D, respectively. CVD event occurrence was highest in Group D. The results of the multivariate analysis also showed that the CVD event rates were significantly higher in Group C (HR: 2.96, P = < .001) and D (HR: 4.22, P < .001) than in Group A.

Conclusion

In patients with advanced CKD, there was a significant correlation of ECG and UCG abnormalities with CVD events. Additionally, those having both types of abnormalities may have a higher risk of coronary artery disease than other groups.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339–52.CrossRefPubMed Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339–52.CrossRefPubMed
2.
go back to reference Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation. 2016;133:518–36.CrossRefPubMed Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation. 2016;133:518–36.CrossRefPubMed
3.
go back to reference Briasoulis A, Bakris GL. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep. 2013;15:340.CrossRefPubMed Briasoulis A, Bakris GL. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep. 2013;15:340.CrossRefPubMed
4.
go back to reference Aiumtrakul N, Kittithaworn A, Supasyndh O, et al. Prediction of cardiovascular outcome by estimated glomerular filtration rate among high-risk patients: a Thai nationwide cohort study. Clin Exp Nephrol. 2022;26:1180–93.CrossRefPubMed Aiumtrakul N, Kittithaworn A, Supasyndh O, et al. Prediction of cardiovascular outcome by estimated glomerular filtration rate among high-risk patients: a Thai nationwide cohort study. Clin Exp Nephrol. 2022;26:1180–93.CrossRefPubMed
5.
go back to reference Ohtake T, Kobayashi S, Moriya H, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol. 2005;16:1141–8.CrossRefPubMed Ohtake T, Kobayashi S, Moriya H, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol. 2005;16:1141–8.CrossRefPubMed
7.
go back to reference Dobre M, Brateanu A, Rashidi A, et al. Electrocardiogram abnormalities and cardiovascular mortality in elderly patients with CKD. Clin J Am Soc Nephrol. 2012;7:949–56.CrossRefPubMed Dobre M, Brateanu A, Rashidi A, et al. Electrocardiogram abnormalities and cardiovascular mortality in elderly patients with CKD. Clin J Am Soc Nephrol. 2012;7:949–56.CrossRefPubMed
8.
go back to reference Deo R, Shou H, Soliman EZ, et al. Electrocardiographic measures and prediction of cardiovascular and noncardiovascular death in CKD. J Am Soc Nephrol. 2016;27:559–69.CrossRefPubMed Deo R, Shou H, Soliman EZ, et al. Electrocardiographic measures and prediction of cardiovascular and noncardiovascular death in CKD. J Am Soc Nephrol. 2016;27:559–69.CrossRefPubMed
9.
go back to reference Flueckiger P, Pastan S, Goyal A, et al. Associations of ECG interval prolongations with mortality among ESRD patients evaluated for renal transplantation. Ann Transplant. 2014;19:257–68.CrossRefPubMed Flueckiger P, Pastan S, Goyal A, et al. Associations of ECG interval prolongations with mortality among ESRD patients evaluated for renal transplantation. Ann Transplant. 2014;19:257–68.CrossRefPubMed
10.
go back to reference Imaizumi T, Fujii N, Hamano T, et al. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function. Kidney Int. 2023;103:949–61.CrossRefPubMedPubMedCentral Imaizumi T, Fujii N, Hamano T, et al. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function. Kidney Int. 2023;103:949–61.CrossRefPubMedPubMedCentral
11.
go back to reference Greig D, Austin PC, Zhou L, et al. Ischemic electrocardiographic abnormalities and prognosis in decompensated heart failure. Circ Heart Fail. 2014;7:986–93.CrossRefPubMed Greig D, Austin PC, Zhou L, et al. Ischemic electrocardiographic abnormalities and prognosis in decompensated heart failure. Circ Heart Fail. 2014;7:986–93.CrossRefPubMed
12.
go back to reference Wagner GS, Macfarlane P, Wellens H, American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American heart association electrocardiography and arrhythmias committee, council on clinical cardiology; the American college of cardiology foundation; and the heart rhythm society: endorsed by the international society for computerized electrocardiology. Circulation. 2009;119:e262-270.CrossRefPubMed Wagner GS, Macfarlane P, Wellens H, American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American heart association electrocardiography and arrhythmias committee, council on clinical cardiology; the American college of cardiology foundation; and the heart rhythm society: endorsed by the international society for computerized electrocardiology. Circulation. 2009;119:e262-270.CrossRefPubMed
13.
go back to reference Fahy GJ, Pinski SL, Miller DP, et al. Natural history of isolated bundle branch block. Am J Cardiol. 1996;77:1185–90.CrossRefPubMed Fahy GJ, Pinski SL, Miller DP, et al. Natural history of isolated bundle branch block. Am J Cardiol. 1996;77:1185–90.CrossRefPubMed
14.
go back to reference Surawicz B, Childers R, Deal BJ, American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American heart association electrocardiography and arrhythmias committee, council on clinical cardiology; the American college of cardiology foundation; and the heart rhythm society. endorsed by the international society for computerized electrocardiology. J Am Coll Cardiol. 2009;53:976–81.CrossRefPubMed Surawicz B, Childers R, Deal BJ, American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American heart association electrocardiography and arrhythmias committee, council on clinical cardiology; the American college of cardiology foundation; and the heart rhythm society. endorsed by the international society for computerized electrocardiology. J Am Coll Cardiol. 2009;53:976–81.CrossRefPubMed
15.
go back to reference American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation. 2006;114:e84-231. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation. 2006;114:e84-231.
16.
go back to reference Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28:1–39.CrossRefPubMed Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28:1–39.CrossRefPubMed
17.
go back to reference Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.CrossRefPubMed Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.CrossRefPubMed
18.
go back to reference Rucker D, Tonelli M. Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol. 2009;5:287–96.CrossRefPubMed Rucker D, Tonelli M. Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol. 2009;5:287–96.CrossRefPubMed
19.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed
20.
go back to reference Tanaka K, Watanabe T, Takeuchi A, CKD-JAC investigators, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91:227–34.CrossRefPubMed Tanaka K, Watanabe T, Takeuchi A, CKD-JAC investigators, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91:227–34.CrossRefPubMed
21.
go back to reference Fox CS, Matsushita K, Woodward M, et al. Chronic kidney disease prognosis consortium. associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380:1662–73.CrossRefPubMedPubMedCentral Fox CS, Matsushita K, Woodward M, et al. Chronic kidney disease prognosis consortium. associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380:1662–73.CrossRefPubMedPubMedCentral
23.
go back to reference Connolly DC, Elveback LR, Oxman HA. Coronary heart disease in residents of Rochester, Minnesota. IV. Prognostic value of the resting electrocardiogram at the time of initial diagnosis of angina pectoris. Mayo Clin Proc. 1984;59:247–50.CrossRefPubMed Connolly DC, Elveback LR, Oxman HA. Coronary heart disease in residents of Rochester, Minnesota. IV. Prognostic value of the resting electrocardiogram at the time of initial diagnosis of angina pectoris. Mayo Clin Proc. 1984;59:247–50.CrossRefPubMed
24.
go back to reference Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. a collaborative project of the united states renal data system/national institutes of health and the national registry of myocardial infarction. Am Heart J. 2012;163:399–406.CrossRefPubMedPubMedCentral Shroff GR, Frederick PD, Herzog CA. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. a collaborative project of the united states renal data system/national institutes of health and the national registry of myocardial infarction. Am Heart J. 2012;163:399–406.CrossRefPubMedPubMedCentral
25.
26.
27.
go back to reference Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines, and the American association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2014;64:1929–49.CrossRefPubMed Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines, and the American association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2014;64:1929–49.CrossRefPubMed
28.
go back to reference Yamada S, Ishii H, Takahashi H, et al. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol. 2010;5:1793–8.CrossRefPubMedPubMedCentral Yamada S, Ishii H, Takahashi H, et al. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol. 2010;5:1793–8.CrossRefPubMedPubMedCentral
29.
go back to reference Payne J, Sharma S, De Leon D, et al. Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2012;27:694–700.CrossRefPubMed Payne J, Sharma S, De Leon D, et al. Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2012;27:694–700.CrossRefPubMed
30.
go back to reference Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:1823–38.CrossRefPubMed Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:1823–38.CrossRefPubMed
31.
go back to reference Edmonston DL, Pun PH. Coronary artery disease in chronic kidney disease: highlights from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2020;97:642–4.CrossRefPubMed Edmonston DL, Pun PH. Coronary artery disease in chronic kidney disease: highlights from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2020;97:642–4.CrossRefPubMed
32.
go back to reference Venkatesh S, O’Neal WT, Broughton ST, Shah AJ, Soliman EZ. Utility of normal findings on electrocardiogram and echocardiogram in subjects ≥ 65 years. Am J Cardiol. 2017;119:856–61.CrossRefPubMed Venkatesh S, O’Neal WT, Broughton ST, Shah AJ, Soliman EZ. Utility of normal findings on electrocardiogram and echocardiogram in subjects ≥ 65 years. Am J Cardiol. 2017;119:856–61.CrossRefPubMed
33.
go back to reference Knuuti J, Wijns W, Saraste A, ESC Scientific Document Group, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.CrossRefPubMed Knuuti J, Wijns W, Saraste A, ESC Scientific Document Group, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–77.CrossRefPubMed
34.
go back to reference Fihn SD, Gardin JM, Abrams J, American College of Cardiology Foundation/American Heart Association Task Force, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354-471.PubMed Fihn SD, Gardin JM, Abrams J, American College of Cardiology Foundation/American Heart Association Task Force, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354-471.PubMed
35.
go back to reference Sharma K, Kohli P, Gulati M. An update on exercise stress testing. Curr Probl Cardiol. 2012;37:177–202.CrossRefPubMed Sharma K, Kohli P, Gulati M. An update on exercise stress testing. Curr Probl Cardiol. 2012;37:177–202.CrossRefPubMed
Metadata
Title
Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease
Authors
Ken Hirabayashi
Hideki Fujii
Keiji Kono
Satoshi Yamatani
Mao Shimizu
Kentaro Watanabe
Kazuo Sakamoto
Shunsuke Goto
Shinichi Nishi
Publication date
23-12-2023
Publisher
Springer Nature Singapore
Published in
Clinical and Experimental Nephrology / Issue 4/2024
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-023-02437-8

Other articles of this Issue 4/2024

Clinical and Experimental Nephrology 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.